Cleared Traditional

K160943 - Bite Away

K160943 is an FDA 510(k) clearance for Bite Away, manufactured by Riemser Pharma. The device is a Class 2 Physical Medicine device with product code IRT cleared through the Traditional 510(k) pathway after a 143-day FDA review.

K160943 · Riemser Pharma · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2016
Decision
143d
Days
Class 2
Risk

K160943 is an FDA 510(k) clearance for the Bite Away. Classified as Pad, Heating, Powered (product code IRT), Class II - Special Controls.

Submitted by Riemser Pharma (Greifswald-Insel Riems, DE). The FDA issued a Cleared decision on August 26, 2016 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5740 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Riemser Pharma devices

FDA 510(k) Submission Details - K160943

510(k) Number K160943 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2016
Decision Date August 26, 2016
Days to Decision 143 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 115d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IRT Device Classification - Class 2, Special Controls

Product Code IRT Pad, Heating, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.